期刊
FUTURE MEDICINAL CHEMISTRY
卷 7, 期 18, 页码 2451-2467出版社
FUTURE SCI LTD
DOI: 10.4155/fmc.15.161
关键词
-
资金
- NIH [AG37609]
- NATIONAL INSTITUTE ON AGING [R01AG037609] Funding Source: NIH RePORTER
Alzheimer's disease (AD) is the most common cause of dementia with no cure at present. Cholesterol metabolism is closely associated with AD at several stages. ACAT1 converts free cholesterol to cholesteryl esters, and plays important roles in cellular cholesterol homeostasis. Recent studies show that in a mouse model, blocking ACAT1 provides multiple beneficial effects on AD. Here we review the current evidence that implicates ACAT1 as a therapeutic target for AD. We also discuss the potential usage of various ACAT inhibitors currently available to treat AD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据